Colistin sulfate

硫酸多粘菌素E

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameColistin sulfate
Drug Alias NameKolistino sulfatas可立斯丁Colistine, sulfate de多粘菌素ESulfato de colistina +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Acute Kidney InjuryNephrosis +[12] 
Global Approved IndicationsEnteritisDysentery, BacillaryBacterial Infections
Approved Indications in ChinaEnteritisDysentery, Bacillary
Original Approved Country/TerritoryUnited States
Original Approved Date1962/05/17
Country/TerritoryUnited StatesThailandGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeni Suef UniversityOctober 6 UniversityYangzhou Pharmaceutical Co Ltd
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Endo Pharmaceuticals IncFriedrich-Schiller University Of Jena +[4] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Acute Kidney InjuryNephrosis +[6] 
Inactive IndicationsCystic FibrosisPneumoniaBronchitis +[6] 

Other Information

ATC CodeA07AA10J01XB01
Related LinksWikipediaDrugBankKEGG